Multiple dose Phase II study of IPH1101 in monotherapy or associated with a low dose of IL2 (2MIU) in non previously treated hepatitis C patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002139-94

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to assess the effect on viral load of IPH1101 administered in monotherapy or in association with a low dose of IL2 (2 MIU) in naïve hepatitis C patients.


Critère d'inclusion

  • Non previously treated Hepatitis C patients

Liens